Stocks › TGTX
TG Therapeutics TGTX
US equityMarket cap rank #1443
$63.34 −$1.54 (-2.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $63.21 -0.21%
Open$64.10
Prev close$64.88
Day range$63.12 – $65.64
Volume2.09M
Market cap$9.57B
P/E (TTM)94.5
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$259.94M+60.7% YoY
Operating profit$85.90M+192.5% YoY
Net profit$55.46M-85.8% YoY
Diluted EPS$0.35-85.6% YoY
Free cash flow$44.95M+293.5% YoY
Operating cash flow$45.23M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin82.7%
Operating margin21.5%
Net margin11.8%
Return on equity18.0%
Return on assets8.1%
Return on invested capital12.7%
Current ratio4.50
Liabilities / assets64.1%
Cash & investments$504.67M
Total debt$752.53M
Net cash (debt)-$247.86M
Free cash flow / sales9.5%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $259.94M | $240.34M | $204.92M | $616.29M | $192.57M |
| Total Operating Revenue | $259.94M | $240.34M | $204.92M | $616.29M | $192.57M |
| Cost of Revenue | $42.08M | $41.19M | $33.51M | $100.71M | $38.14M |
| Gross Profit | $217.86M | $199.14M | $171.41M | $515.57M | $154.43M |
| Operating Expense | $131.96M | $177.47M | $136.61M | $392.25M | $103.94M |
| Selling and Admin Expenses | $88.22M | $90.20M | $93.09M | $248.65M | $66.38M |
| -General & Admin Expense | $88.22M | $90.20M | $93.09M | $248.65M | $66.38M |
| Research & Development | $43.74M | $87.27M | $43.52M | $143.60M | $37.56M |
| Operating Profit | $85.90M | $21.67M | $34.80M | $123.32M | $50.49M |
| Net Non-Operating Interest Income (Expense) | -$15.82M | -$16.57M | -$7.67M | -$26.73M | -$6.53M |
| Non-Operating Interest Expense | $15.82M | $16.57M | $7.67M | $26.73M | $6.53M |
| Other Income (Expense) | $3.78M | $5.13M | -$6.77M | $10.79M | $1.13M |
| Special Income (Charges) | $0.00 | $0.00 | -$9.15M | – | – |
| Other Non-Operating Income (Expenses) | $3.78M | $5.13M | $2.39M | $10.79M | $1.13M |
| Pretax Profit | $73.86M | $10.23M | $20.36M | $107.39M | $45.09M |
| Tax | $18.40M | $2.45M | $586,000.00 | -$339.79M | $22.06M |
| Net Profit | $55.46M | $7.78M | $19.78M | $447.18M | $23.04M |
| Profit from Continuing Operations | $55.46M | $7.78M | $19.78M | $447.18M | $23.04M |
| Net Income to Parent Company | $55.46M | $7.78M | $19.78M | $447.18M | $23.04M |
| Net Income to Common Stockholders | $55.46M | $7.78M | $19.78M | $447.18M | $23.04M |
| Basic EPS | $0.39 | $0.05 | $0.14 | $3.10 | $0.16 |
| Diluted EPS | $0.35 | $0.05 | $0.12 | $2.77 | $0.14 |
| -Less:Other Special Charges | – | – | $9.15M | – | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.59B | $1.64B | $1.53B | $1.06B | $1.06B |
| Total Current Assets | $1.17B | $1.15B | $1.09B | $630.76M | $630.76M |
| Cash and Cash Equivalents & Short-Term Investments | $504.67M | $552.25M | $514.43M | $141.97M | $141.97M |
| -Cash and Cash Equivalents | $429.38M | $482.58M | $442.21M | $79.15M | $79.15M |
| -Short Term Investments | $75.30M | $69.67M | $72.22M | $62.82M | $62.82M |
| Receivables | $416.82M | $401.57M | $392.05M | $305.63M | $305.63M |
| -Accounts Receivable | $416.82M | $401.57M | $392.05M | $305.63M | $305.63M |
| Inventory | $194.32M | $147.97M | $129.03M | $125.59M | $125.59M |
| Other Current Assets | $55.64M | $43.90M | $51.46M | $57.58M | $57.58M |
| Total Non-Current Assets | $420.81M | $493.94M | $441.87M | $432.49M | $432.49M |
| Net PPE | $6.83M | $7.09M | $6.48M | $6.28M | $6.28M |
| -Gross PPE | $6.83M | $7.09M | $6.48M | $6.28M | $6.28M |
| Investments and Advances | $56.04M | $64.37M | $87.88M | $74.83M | $74.83M |
| -Available for Sale Securities | $4.00M | – | – | – | – |
| -Held to Maturity Securities | $52.04M | $64.37M | $61.54M | $59.14M | $59.14M |
| Non-Current Deferred Assets | $333.38M | $343.43M | $344.14M | $348.00M | $348.00M |
| Other Non-Current Assets | $24.56M | $79.06M | $3.37M | $3.39M | $3.39M |
| Total Liabilities | $1.02B | $1.04B | $945.71M | $415.23M | $415.23M |
| Total Current Liabilities | $260.53M | $268.49M | $187.11M | $153.76M | $153.76M |
| Short-Term Debt and Capital Lease Obligation | $1.84M | $1.91M | $1.82M | $1.04M | $1.04M |
| -Current Capital Lease Obligation | $1.84M | $1.91M | $1.82M | $1.04M | $1.04M |
| Current Deferred Liabilities | $26.10M | $16.83M | $17.19M | $21.23M | $21.23M |
| Other Current Liabilities | $1.22M | $857,000.00 | $596,000.00 | $2.12M | $2.12M |
| Total Non-Current Liabilities | $759.60M | $767.05M | $758.60M | $261.47M | $261.47M |
| Long Term Debt and Capital Lease Obligation | $752.53M | $752.53M | $751.74M | $252.67M | $252.67M |
| -Long Term Debt | $745.63M | $745.39M | $745.14M | $245.65M | $245.65M |
| -Long Term Capital Lease Obligation | $6.90M | $7.14M | $6.60M | $7.02M | $7.02M |
| Non-Current Deferred Liabilities | $7.07M | $14.53M | $6.86M | $8.81M | $8.81M |
| Total Equity | $572.13M | $604.08M | $583.13M | $648.02M | $648.02M |
| Stockholders' Equity | $572.13M | $604.08M | $583.13M | $648.02M | $648.02M |
| Capital Stock | $160,000.00 | $160,000.00 | $160,000.00 | $159,000.00 | $159,000.00 |
| -Common Stock | $160,000.00 | $160,000.00 | $160,000.00 | $159,000.00 | $159,000.00 |
| Additional Paid-In Capital | $1.87B | $1.86B | $1.85B | $1.83B | $1.83B |
| Retained Earnings | -$998.99M | -$1.05B | -$1.06B | -$1.08B | -$1.08B |
| Less: Treasury Stock | -$300.22M | -$200.23M | -$200.23M | -$100.23M | -$100.23M |
| -Long Term Equity Investment | – | – | $26.35M | $15.69M | $15.69M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $45.23M | $39.26M | -$17.89M | -$24.77M | $19.66M |
| Net cash flow from continuing operations | $45.23M | $39.26M | -$17.89M | -$24.77M | $19.66M |
| Net Income from Continuing Operations | $55.46M | $7.78M | $19.78M | $447.18M | $23.04M |
| Gain/Loss from Continuing Operations | $0.00 | $0.00 | $9.15M | – | – |
| Depreciation & Depletion & Amortization | $119,000.00 | $96,000.00 | $80,000.00 | $244,000.00 | $67,000.00 |
| Deferred Tax | $10.05M | $708,000.00 | $3.86M | -$348.00M | $18.63M |
| Other Non-Cash Items | $728,000.00 | $1.21M | $946,000.00 | $2.99M | $600,000.00 |
| Change in Working Capital | -$46.99M | $3.07M | -$69.76M | -$194.54M | -$44.54M |
| -Change in Receivables | -$15.26M | -$9.52M | -$86.42M | -$176.44M | -$40.24M |
| -Change in Inventory | $9.50M | -$66.82M | -$13.28M | -$33.45M | $563,000.00 |
| -Change in Payables and Accrued Expense | -$28.60M | $59.21M | $27.30M | $55.88M | $2.01M |
| -Change in Other Current Assets | -$14.27M | $13.57M | $10.66M | -$42.43M | -$1.91M |
| -Change in Other Current Liabilities | -$179,000.00 | -$670,000.00 | -$2.04M | -$4.48M | -$253,000.00 |
| -Change In Other Working Capital | $1.82M | $7.30M | -$5.99M | $6.39M | -$4.71M |
| Net cash flow from investing | $1.33M | $1.03M | -$9.86M | $13.80M | -$15.64M |
| Net Cash Flow from Continuing Investing Activities | $1.33M | $1.03M | -$9.86M | $13.80M | -$15.64M |
| Net PPE Purchase and Sale | -$282,000.00 | -$293,000.00 | -$51,000.00 | -$214,000.00 | -$67,000.00 |
| Net Investment Purchase and Sale | $2.61M | $1.32M | -$9.81M | $14.01M | -$16.82M |
| Financing Cash Flow | -$99.75M | $85,000.00 | $390.83M | -$89.73M | $1.06M |
| Net Cash Flow from Continuing Financing Activities | -$99.75M | $85,000.00 | $390.83M | -$89.73M | $1.06M |
| Net Issuance Payments Of Debt | $0.00 | $0.00 | $492.66M | $0.00 | $0.00 |
| Net Common Stock Issuance | -$100.00M | $0.00 | -$99.99M | -$91.24M | $0.00 |
| Cash Dividends Paid | $0.00 | $0.00 | $0.00 | – | – |
| Proceeds from Stock Option Exercised | $253,000.00 | $85,000.00 | $763,000.00 | $1.51M | $1.06M |
| Ending Cash Balance | $430.75M | $483.94M | $443.56M | $80.49M | $80.49M |
| Net Change in Cash | -$53.19M | $40.38M | $363.07M | -$100.70M | $5.08M |
| Beginning Cash Balance | $483.94M | $443.56M | $80.49M | $181.19M | $75.41M |
| Free Cash Flow | $44.95M | $38.97M | -$17.95M | -$24.99M | $19.59M |
No comments yet — be the first to weigh in on TGTX.
Sign in to join the discussion.